Lymphoma & Myeloma Membership
Leadership
Membership
-
-
ELIZABETH K. O'DONNELL, MD Dana-Farber Cancer InstituteCANCER RISK, PREVENTION, AND EARLY DETECTION, LYMPHOMA AND MYELOMA -
OREOFE O. ODEJIDE, MD Dana-Farber Cancer InstituteCANCER CARE DELIVERY RESEARCH, LYMPHOMA AND MYELOMA -
CHRISTOPHER OTT, PhD Massachusetts General HospitalDEVELOPMENTAL THERAPEUTICS, LYMPHOMA AND MYELOMA
-
-
-
NOOPUR RAJE, MD Massachusetts General HospitalLYMPHOMA AND MYELOMA -
PAUL G. RICHARDSON, MD Dana-Farber Cancer InstituteANGIOGENESIS, INVASION AND METASTASIS, DEVELOPMENTAL THERAPEUTICS, LYMPHOMA AND MYELOMA -
SCOTT J. RODIG, MD, PhD Brigham And Women's HospitalCANCER IMMUNOLOGY, LYMPHOMA AND MYELOMA
-
-
-
STEVEN P. TREON, MD, PhD Dana-Farber Cancer InstituteCANCER IMMUNOLOGY, LYMPHOMA AND MYELOMA -
ANNICK D. VAN DEN ABBEELE, MD, FACR, FICIS Dana-Farber Cancer InstituteCANCER IMAGING, LUNG CANCER, LYMPHOMA AND MYELOMA, SARCOMA -
LOREN D. WALENSKY, MD, PhD Dana-Farber Cancer InstituteDEVELOPMENTAL THERAPEUTICS, LYMPHOMA AND MYELOMA
-
